Heterogeneous treatment effects of intensive glycemic control on major adverse cardiovascular events in the ACCORD and VADT trials: a machine-learning analysis

被引：0
|
作者：
Justin A. Edward
Kevin Josey
Gideon Bahn
Liron Caplan
Jane E. B. Reusch
Peter Reaven
Debashis Ghosh
Sridharan Raghavan
机构：
[1] University of Colorado School of Medicine,Division of Cardiology
[2] Rocky Mountain,Department of Veterans Affairs Eastern Colorado Healthcare System
[3] Regional VA Medical Center,Department of Biostatistics and Informatics
[4] Medicine Service (111),Department of Veterans Affairs
[5] Colorado School of Public Health,Division of Rheumatology
[6] Hines VA Hospital,Division of Endocrinology, Metabolism, and Diabetes
[7] University of Colorado School of Medicine,Division of Biomedical Informatics and Personalized Medicine
[8] University of Colorado School of Medicine,undefined
[9] Department of Veterans Affairs Phoenix VA Medical Center,undefined
[10] University of Colorado School of Medicine,undefined
[11] Colorado Cardiovascular Outcomes Research Consortium,undefined
来源：
Cardiovascular Diabetology | / 21卷
关键词：
Machine learning; Glycemic control; Subgroup effects; Heterogeneity; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Heterogeneous treatment effects of intensive glycemic control on major adverse cardiovascular events in the ACCORD and VADT trials: a machine-learning analysis
    Edward, Justin A.
    Josey, Kevin
    Bahn, Gideon
    Caplan, Liron
    Reusch, Jane E. B.
    Reaven, Peter
    Ghosh, Debashis
    Raghavan, Sridharan
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [2] Intensive glycemic control Implications of the ACCORD, ADVANCE, and VADT trials for family physicians
    Dhar, Gauranga Chandra
    CANADIAN FAMILY PHYSICIAN, 2009, 55 (08) : 803 - 804
  • [3] Predictors of Death and Major Adverse Cardiovascular Events in the ACCORD Trial Identified by Random Survival Forest Based Machine-Learning
    Shamsuzzaman, Md
    Navarro, Almario Eileen
    Patel, Tejas
    Csako, Gyorgy
    Wu, Colin O.
    Tian, Xin
    Tesfaldet, Bereket
    Fleg, Jerome
    Kettermann, Anna
    Gandotra, Charu
    Sopko, George
    Sviglin, Helena
    Cooper, Lawton
    Coady, Sean
    Banerjee, Avantika
    Farooque, Nashwan
    Dandi, Gauri
    Hoque, Laboni
    Cure, Carlos
    Kirby, Ruth
    Liu, Lijuan
    Chen, Jue
    Yan, Ye
    Chowdhury, Iffat
    Burkhart, Keith
    Calis, Karim
    Leifer, Eric
    Szarfman, Ana
    Domanski, Michael
    Pucino, Frank
    Rosenberg, Yves
    Hasan, Ahmed A.
    CIRCULATION, 2018, 138
  • [4] Heterogeneous Treatment Effects of Intensive Glycemic Control on Kidney Microvascular Outcomes and Mortality in ACCORD
    Charu, Vivek
    Liang, Jane W.
    Chertow, Glenn M.
    Li, June
    Montez-Rath, Maria E.
    Geldsetzer, Pascal
    de Boer, Ian H.
    Tian, Lu
    Tamura, Manjula Kurella
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (02): : 216 - 228
  • [5] Machine-Learning Approaches for Major Adverse Cardiovascular Events (MACE) Prediction in Patients on Hemodialysis
    Chen Cheng-Hsu
    Hou Shun Fang
    Wang Min-Shian
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [6] Intensive Glycemic Control Can Reduce Major Adverse Cardiovascular Events (MACE): A Bayesian's Narrative
    Shao, Hui
    Yang, Shuang
    Fonseca, Vivian
    Bian, Jiang
    Shi, Lizheng
    DIABETES, 2020, 69
  • [7] Implications of intensive glycemic control on cardiovascular disease: Early reports from the ACCORD and ADVANCE trials
    Shin, Soo Yeon
    Nesto, Richard W.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2008, 9 (01) : 1 - 4
  • [8] Can machine learning augment clinician adjudication of events in cardiovascular trials? A case study of major adverse cardiovascular events (MACE) across CVRM trials
    Lea, H.
    Hutchinson, E.
    Meeson, A.
    Nampally, S.
    Dennis, G.
    Wallander, M.
    Andersson, T.
    Persson, A.
    Johnston, S. C.
    Weatherall, J.
    Khan, F.
    Khader, S.
    EUROPEAN HEART JOURNAL, 2021, 42 : 3061 - 3061
  • [9] Certain Patient Subgroups with Type 2 Diabetes May Benefit from Intensive Glycemic and Blood Pressure Control from Reductions in Major Adverse Cardiovascular Events (MACE) : A Machine Learning-Based Post Hoc Analysis of ACCORD Trial Data
    Kianmehr, Hamed
    Zhang, Ping
    Ospina, Naykky Singh
    Shi, Lizheng
    Fonseca, Vivian
    Guo, Jingchuan
    Shao, Hui
    DIABETES, 2022, 71
  • [10] Glycemic Control, Preexisting Cardiovascular Disease, and Risk of Major Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: Systematic Review With Meta-Analysis of Cardiovascular Outcome Trials and Intensive Glucose Control Trials
    Giugliano, Dario
    Maiorino, Maria Ida
    Bellastella, Giuseppe
    Chiodini, Paolo
    Esposito, Katherine
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (12):
12345